Patents by Inventor Yunike Akasaka

Yunike Akasaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic agent for fibrosis
    Patent number: 11326163
    Abstract: Disclosed is a phosphorylation inhibitor of SMAD2/3 protein or a therapeutic agent for fibrosis which contains as an active ingredient, a nucleic acid that suppresses NEK6 (NIMA-related serine/threonine kinase 6) gene expression.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: May 10, 2022
    Assignee: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Kazuhisa Nakao, Junichi Ishiyama, Wataru Ichikawa, Atsushi Masui, Yunike Akasaka, Hidekazu Toyofuku, Aya Honda
  • THERAPEUTIC AGENT FOR FIBROSIS
    Publication number: 20220088057
    Abstract: Disclosed is an antisense nucleic acid that suppresses NEK6 gene expression.
    Type: Application
    Filed: January 25, 2019
    Publication date: March 24, 2022
    Applicant: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Kazuhisa NAKAO, Junichi ISHIYAMA, Wataru ICHIKAWA, Atsushi MASUI, Yunike AKASAKA, Aya HONDA
  • THERAPEUTIC AGENT FOR FIBROSIS
    Publication number: 20210087556
    Abstract: Disclosed is a phosphorylation inhibitor of SMAD2/3 protein or a therapeutic agent for fibrosis which contains as an active ingredient, a nucleic acid that suppresses NEK6 (NIMA-related serine/threonine kinase 6) gene expression.
    Type: Application
    Filed: July 30, 2018
    Publication date: March 25, 2021
    Applicant: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Kazuhisa Nakao, Junichi Ishiyama, Wataru Ichikawa, Atsushi Masui, Yunike Akasaka, Hidekazu Toyofuku, Aya Honda
  • AMPK activator screening method, and AMPK activator
    Patent number: 9863955
    Abstract: A method for screening an AMPK activator, wherein inhibition of an interaction between prohibitin and AMPK is used as an index is provided. Besides, an AMPK activator comprising, as an active ingredient, a compound inhibiting an interaction between prohibitin and AMPK, and a prohibitin-AMPK complex are also provided.
    Type: Grant
    Filed: May 16, 2013
    Date of Patent: January 9, 2018
    Assignee: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Tomohiro Ide, Naoki Kobayashi, Yunike Akasaka, Takashi Komine, Koji Murakami
  • AMPK ACTIVATOR SCREENING METHOD, AND AMPK ACTIVATOR
    Publication number: 20150126387
    Abstract: A method for screening an AMPK activator, wherein inhibition of an interaction between prohibitin and AMPK is used as an index is provided. Besides, an AMPK activator comprising, as an active ingredient, a compound inhibiting an interaction between prohibitin and AMPK, and a prohibitin-AMPK complex are also provided.
    Type: Application
    Filed: May 16, 2013
    Publication date: May 7, 2015
    Applicant: Kyorin Pharmaceutical Co., Ltd.
    Inventors: Tomohiro Ide, Naoki Kobayashi, Yunike Akasaka, Takashi Komine, Koji Murakami